Enbiosis Biotechnology Limited is a company dedicated to producing AI-driven,next-generation bioengineering and biotechnology solutions that enhance human health and quality of life. By utilizing microbial organisms to form a symbiotic relationship with the human body, Enbiosis aims to create innovative products and services. Compared to the current gold standard, we offer a personalised, targeted, and potentially more effective and more cost-effective approach to managing IBS. Our microbiome-based treatment takes into account an individual’s unique gut microbial profile, and can be tailored to their specific needs. This is in contrast to the current gold standard, which uses a one-size-fits-all approach.